BCG as a Case Study for Precision Vaccine Development: Lessons From Vaccine Heterogeneity, Trained Immunity, and Immune Ontogeny

Frontiers in Microbiology - Switzerland
doi 10.3389/fmicb.2020.00332
Full Text
Abstract

Available in full text

Categories
Microbiology
Date
Authors
Publisher

Frontiers Media SA

Related search

Trained Immunity: A New Avenue for Tuberculosis Vaccine Development

Journal of Internal Medicine
Internal Medicine
2015English

Development of a Novel Recombinant BCG for Tuberculosis Vaccine

Japanese Journal of Leprosy
DermatologyMedicineInfectious Diseases
2013English

Ipr1 Modified BCG as a Novel Vaccine Induces Stronger Immunity Than BCG Against Tuberculosis Infection in Mice

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Lessons From the Chinese Defective Vaccine Case

The Lancet Infectious Diseases
Infectious Diseases
2019English

Arthritis as a Complication of Intravesical BCG Vaccine

BMJ
1994English

Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine

Viruses
VirologyInfectious Diseases
2018English

BCG Vaccine: Tuberculosis—Cancer

British Journal of Cancer
Cancer ResearchOncology
1980English

Balancing Trained Immunity With Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated With Attenuated Mycobacterium Tuberculosis or Mycobacterium Bovis BCG Vaccine

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2016English

The Immune Space: A Concept and Template for Rationalizing Vaccine Development

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy